1,3-dibromo-5-chlorobenzene (CED0037964)

Record Information
Version1.0
Creation Date2026-08-23 08:28:11 UTC
Update Date2026-08-23 08:28:11 UTC
SynCED IDCED0037964
Secondary Accession Numbers
  • CHEM229865
Identification
Common Name1,3-dibromo-5-chlorobenzene
ClassSmall Molecule
Description
1,3-dibromo-5-chlorobenzene belongs to the halobenzenes, a subclass of benzene and substituted derivatives within the organic compounds. This benzenoid compound has the formula C6H3Br2Cl and an average molecular weight of 270.35 g/mol.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC6H3Br2Cl
Average Molecular Mass270.350 g/mol
Monoisotopic Mass267.829 g/mol
CAS Registry Number14862-52-3
IUPAC NameNot Available
Traditional NameNot Available
SMILESNot Available
InChI IdentifierInChI=1S/C6H3Br2Cl/c7-4-1-5(8)3-6(9)2-4/h1-3H
InChI KeyFNKCOUREFBNNHG-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
259.0 Log mg/kg [150:460]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000688Glass Coatings?Glass coatings are synthetic chemical formulations applied to glass surfaces to enhance properties such as durability, UV resistance, and aesthetic appeal.Building & ConstructionPubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
CEDs000739Inks?Inks are complex mixtures composed of pigments or dyes, solvents, resins, and additives used primarily for printing and writing applications.Paper, pulp & fiber productsPubChem
CEDs03363Organic Solar CellsElectrical & Electronic EquipmentPMC13074071
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureGlutamine synthetase, chloroplasticP25462Zea maysPredicted (SEA)
Prediction Confidence Score
0.233
Applicability Domain
0.233 Low confidence
Statistical Significance
6.60e-04
Supporting Reference Compounds
1
E-value
5.13805
Click to view 3D structureProline--tRNA ligase, cytoplasmicP78600Candida albicansPredicted (SEA)
Prediction Confidence Score
0.233
Applicability Domain
0.233 Low confidence
Statistical Significance
0.0044
Supporting Reference Compounds
1
E-value
34.4872
Subtilisin BL structureClick to view 3D structureSubtilisin BLP29599Bacillus lentusPredicted (SEA)
Prediction Confidence Score
0.215
Applicability Domain
0.222 Low confidence
Statistical Significance
1.20e-04
Supporting Reference Compounds
2
E-value
0.934191
Unconventional myosin-Va structureClick to view 3D structureUnconventional myosin-VaQ02440Gallus gallusPredicted (SEA)
Prediction Confidence Score
0.212
Applicability Domain
0.212 Low confidence
Statistical Significance
2.00e-04
Supporting Reference Compounds
1
E-value
1.55698
Myosin light chain kinase 2, skeletal/cardiac muscle structureClick to view 3D structureMyosin light chain kinase 2, skeletal/cardiac muscleP07313Oryctolagus cuniculusPredicted (SEA)
Prediction Confidence Score
0.212
Applicability Domain
0.212 Low confidence
Statistical Significance
2.00e-04
Supporting Reference Compounds
1
E-value
1.55698
5-hydroxytryptamine receptor 2B structureClick to view 3D structure5-hydroxytryptamine receptor 2BP41595HumansPredicted (SEA)
Prediction Confidence Score
0.207
Applicability Domain
0.269 Low confidence
Statistical Significance
0.7355
Supporting Reference Compounds
686
E-value
5726.04
Aryl hydrocarbon receptor structureClick to view 3D structureAryl hydrocarbon receptorP35869HumansPredicted (SEA)
Prediction Confidence Score
0.203
Applicability Domain
0.238 Low confidence
Statistical Significance
0.0902
Supporting Reference Compounds
42
E-value
702.278
Mitogen-activated protein kinase 14 structureClick to view 3D structureMitogen-activated protein kinase 14Q16539HumansPredicted (SEA)
Prediction Confidence Score
0.2
Applicability Domain
0.269 Low confidence
Statistical Significance
0.8174
Supporting Reference Compounds
668
E-value
6363.55
Mitogen-activated protein kinase 1 structureClick to view 3D structureMitogen-activated protein kinase 1P28482HumansPredicted (SEA)
Prediction Confidence Score
0.2
Applicability Domain
0.269 Low confidence
Statistical Significance
0.8317
Supporting Reference Compounds
763
E-value
6474.41
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP28335HumansPredicted (SEA)
Prediction Confidence Score
0.2
Applicability Domain
0.269 Low confidence
Statistical Significance
0.8073
Supporting Reference Compounds
823
E-value
6285.08
Tyrosine-protein kinase Lck structureClick to view 3D structureTyrosine-protein kinase LckP06239HumansPredicted (SEA)
Prediction Confidence Score
0.198
Applicability Domain
0.269 Low confidence
Statistical Significance
0.8939
Supporting Reference Compounds
1130
E-value
6959.33
Epidermal growth factor receptor structureClick to view 3D structureEpidermal growth factor receptorP00533HumansPredicted (SEA)
Prediction Confidence Score
0.198
Applicability Domain
0.269 Low confidence
Statistical Significance
0.9022
Supporting Reference Compounds
1301
E-value
7023.48
Receptor tyrosine-protein kinase erbB-2 structureClick to view 3D structureReceptor tyrosine-protein kinase erbB-2P04626HumansPredicted (SEA)
Prediction Confidence Score
0.196
Applicability Domain
0.269 Low confidence
Statistical Significance
0.8344
Supporting Reference Compounds
674
E-value
6495.66
Vascular endothelial growth factor receptor 1 structureClick to view 3D structureVascular endothelial growth factor receptor 1P17948HumansPredicted (SEA)
Prediction Confidence Score
0.193
Applicability Domain
0.238 Low confidence
Statistical Significance
0.8556
Supporting Reference Compounds
711
E-value
6661.01
Click to view 3D structureStreptokinase AP10520Streptococcus pyogenes serotype M1Predicted (SEA)
Prediction Confidence Score
0.193
Applicability Domain
0.22 Low confidence
Statistical Significance
0.6963
Supporting Reference Compounds
425
E-value
5420.88
Click to view 3D structurePeptidyl-prolyl cis-trans isomerase AP10111Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.189
Applicability Domain
0.189 Low confidence
Statistical Significance
0.0581
Supporting Reference Compounds
1
E-value
452.226
Carbonic anhydrase 2 structureClick to view 3D structureCarbonic anhydrase 2P00918HumansPredicted (SEA)
Prediction Confidence Score
0.189
Applicability Domain
0.208 Low confidence
Statistical Significance
0.7014
Supporting Reference Compounds
472
E-value
5460.27
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)
Prediction Confidence Score
0.188
Applicability Domain
0.269 Low confidence
Statistical Significance
0.8848
Supporting Reference Compounds
861
E-value
6887.79
Dual specificity protein kinase CLK4 structureClick to view 3D structureDual specificity protein kinase CLK4Q9HAZ1HumansPredicted (SEA)
Prediction Confidence Score
0.187
Applicability Domain
0.2 Low confidence
Statistical Significance
0.8995
Supporting Reference Compounds
742
E-value
7002.3
Solute carrier family 22 member 3 structureClick to view 3D structureSolute carrier family 22 member 3O75751HumansPredicted (SEA)
Prediction Confidence Score
0.187
Applicability Domain
0.269 Low confidence
Statistical Significance
0.013
Supporting Reference Compounds
17
E-value
100.893
Sodium-dependent dopamine transporter structureClick to view 3D structureSodium-dependent dopamine transporterQ01959HumansPredicted (SEA)
Prediction Confidence Score
0.187
Applicability Domain
0.269 Low confidence
Statistical Significance
0.8775
Supporting Reference Compounds
506
E-value
6831.19
Alpha-2C adrenergic receptor structureClick to view 3D structureAlpha-2C adrenergic receptorP18825HumansPredicted (SEA)
Prediction Confidence Score
0.186
Applicability Domain
0.269 Low confidence
Statistical Significance
0.7917
Supporting Reference Compounds
386
E-value
6163.71
Cyclin-dependent kinase 5 structureClick to view 3D structureCyclin-dependent kinase 5Q00535HumansPredicted (SEA)
Prediction Confidence Score
0.185
Applicability Domain
0.2 Low confidence
Statistical Significance
0.9161
Supporting Reference Compounds
779
E-value
7131.46
Dual specificity tyrosine-phosphorylation-regulated kinase 1A structureClick to view 3D structureDual specificity tyrosine-phosphorylation-regulated kinase 1AQ13627HumansPredicted (SEA)
Prediction Confidence Score
0.185
Applicability Domain
0.2 Low confidence
Statistical Significance
0.9257
Supporting Reference Compounds
906
E-value
7206.58
Serine/threonine-protein kinase Chk1 structureClick to view 3D structureSerine/threonine-protein kinase Chk1O14757HumansPredicted (SEA)
Prediction Confidence Score
0.184
Applicability Domain
0.2 Low confidence
Statistical Significance
0.9258
Supporting Reference Compounds
807
E-value
7206.97
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available